Lee Hartner
Impact in
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Sarcoma Diagnosis and Treatment 9
- Lung Cancer Diagnosis and Treatment 2
- Oncology 12
- Vascular Tumors and Angiosarcomas 4
- Cancer Diagnosis and Treatment 3
- CAR-T cell therapy research 2
- Co-authors
- Arthur P. Staddon (8 shared papers)Warren Chow (2 shared papers)Kristy Weber (3 shared papers)Brian C. Baumann (2 shared papers)Abigail T. Berman (2 shared papers)William P. Levin (2 shared papers)James D. Kolker (2 shared papers)Eli Glatstein (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Head & Neck (3 papers)Journal of Surgical Oncology (2 papers)Cancer (2 papers)The American Journal of Gastroenterology (1 paper)
- Partner nations
- United StatesPolandIndia
In The Last Decade
Lee Hartner
25 papers receiving 422 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 195
- Toxicology 22
- Rheumatology 68
- Oncology 105
- Hematology 44
Countries citing papers authored by Lee Hartner
This map shows the geographic impact of Lee Hartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Hartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Hartner more than expected).
Fields of papers citing papers by Lee Hartner
This network shows the impact of papers produced by Lee Hartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Hartner. The network helps show where Lee Hartner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Hartner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 99 | |
| 2 | 2016 | 57 | |
| 3 | 2019 | 52 | |
| 4 | 2014 | 40 | |
| 5 | 2010 | 38 | |
| 6 | 2020 | 33 | |
| 7 | 2007 | 21 | |
| 8 | 2017 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 2018 | 11 | |
| 12 | 2014 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2014 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2012 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2009 | 2 | |
| 20 | 2007 | 1 |
About Lee Hartner
Lee Hartner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Otorhinolaryngology and Rheumatology, having authored 26 papers that have together received 431 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (4 papers), Head and Neck Cancer Studies (3 papers), Cancer Diagnosis and Treatment (3 papers), Bone Tumor Diagnosis and Treatments (2 papers), CAR-T cell therapy research (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (195 citations), Toxicology (22 citations), Rheumatology (68 citations), Oncology (105 citations) and Hematology (44 citations). Lee Hartner has collaborated with scholars based in United States, Poland and India. Frequent co-authors include Arthur P. Staddon, Warren Chow, Kristy Weber, Brian C. Baumann, Abigail T. Berman, William P. Levin, James D. Kolker, Eli Glatstein, S. Nagda and Charles B. Simone. Their work appears in journals such as Journal of Clinical Oncology, Head & Neck, Journal of Surgical Oncology, Cancer and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.